Kenya vs Yemen: Population requiring preventive chemotherapy for schistosomiasis
Kenya
4.77 million
in 2024
Yemen
3.85 million
in 2024
Kenya rank
18th
Yemen rank
21st
Population requiring preventive chemotherapy for schistosomiasis over time
- Kenya
- Yemen
How they compare
Kenya currently reports 4.77 million against 3.85 million in Yemen, a difference of 916,400.
That makes Kenya's figure about 1.2 times Yemen's.
The two have swapped places 6 times across 15 shared years of data; in 2010 it was Kenya ahead.
Kenya ranks 18th and Yemen ranks 21st of 52 countries.
Kenya has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Kenya | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 6.35 million | 6.08 million | 262,501 | Kenya |
| 2020s | 4.24 million | 3.75 million | 487,024 | Kenya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Kenya or Yemen?
- Kenya, at 4.77 million against 3.85 million in Yemen as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Kenya and Yemen?
- 916,400, with Kenya ahead.
- How many years of comparable data are there for Kenya and Yemen?
- 15 years are reported by both, from 2010 to 2024.
- How do Kenya and Yemen rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Kenya ranks 18th and Yemen ranks 21st of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.